Condition

Cystic Fibrosis (2)

COVID (1)

COVID-19 (1)

Chronic Rhinosinusitis (1)

Head and Neck Cancer (1)

Overall Status

Completed (2)

Recruiting (2)

Unknown status (1)

Phase

phase 2 (2)

early phase 1 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Boston Children's Hospital (1)

Northwestern University (1)

QuantumLeap Healthcare Collaborative (1)

University Hospital, Tours (1)

University of Jena (1)

Intervention

pulmozyme (5)

placebo (2)

aviptadil acetate (1)

celecoxib famotidine (1)

cyclosporine (1)

ic14 (1)

narsoplimab (1)

radiation therapy (1)

remdesivir (1)

Study Documents

Intervention Type

drug (5)

radiation (1)

Funder Type

Other (5)

Study Type

Interventional (5)

pulmozyme

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID Trial in Boston, Weymouth (Pulmozyme, Placebo)

Recruiting

COVID

Pulmozyme
Placebo

Boston, Massachusetts
+2 more

Dec 7, 2021

Cystic Fibrosis Trial in Tours (Pulmozyme)

Completed

Cystic Fibrosis

Pulmozyme

Tours, France

University Hospital - Tours

Feb 28, 2022

COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)

Recruiting

COVID-19

Remdesivir
+6 more

Birmingham, Alabama
+18 more

Jul 19, 2021

Cystic Fibrosis, Chronic Rhinosinusitis Trial in Jena (Pulmozyme)

Completed

Cystic Fibrosis
Chronic Rhinosinusitis

Pulmozyme

Jena, Thüringen, Germany

Friedrich-Schiller-Universität

Dec 3, 2014

Head Neck Cancer Trial in Chicago (Pulmozyme, Placebo, Radiation Therapy)

Unknown status

Head and Neck Cancer

Pulmozyme
+2 more

Chicago, Illinois

Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ

Jun 25, 2013